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Abstract 
Experiments were performed to test sequence and structural specific interactions of 
proteins with a conserved RNA modification enzyme, which is known as Ime4 in yeast and 
Mettl3 in mammals. Ime4 methylates N6-adenosine bases on mRNA molecules. The goal of this 
project is to gain direct insights into how novel proteins interact with Ime4 to form the 
methyltranferase (MTase) complex and to identify proteins that are essential for Ime4 activity. It 
has been recognized that there are two proteins that interact within the Ime4 complex, which are 
known as Mum2 (a cytoplasmic protein essential for meiotic DNA replication within yeast) and 
Slz1 (a transcription factor). We hypothesize that the N-terminal domain of Ime4 is the location 
of binding of the aforementioned proteins in this complex.  Similarly, we tested whether the 
human ortholog of Ime4 (Mettl3) forms an analogous complex that includes an ortholog of 
Mum2, known as WTAP, and its binding partner WT1. The major approaches include in vivo 
genetic assays in yeast to test protein-protein interactions and the use of recombinant DNA 
technology to construct fusion genes/deletions. The results demonstrate that Mum2 interacts with 
a specific, non-conserved region in the Ime4 N-terminal domain. Furthermore, we discovered a 
new binding partner, Ygl036w, which also interacts with Ime4. Currently, several experiments 
are being carried out with the Mettl3 complex and its hypothesized protein binding partners to 
assess the interactions of this complex.  
 
 
Key Terms: m
6
A, IME4, METTL3, RNA Methylation, MUM2, WT1, WTAP,  
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Introduction 
Importance of protein-protein interactions 
 Protein-protein interactions are essential for the regulation of many processes within 
cells. An understanding of how proteins function as complexes is crucial to understanding how 
organisms live. Proteins regulate all biological systems, and although some proteins perform 
independent functions, most interact with other proteins to perform necessary biological 
activities. Understanding the function of single proteins is essential to understanding the function 
of a protein complex. But because most proteins interact with other proteins to carry out their 
functions, it is important to study the interacting protein in its entirety to fully appreciate a 
protein’s exact function within a cell. 
 Protein-protein interactions are necessary for cell proliferation, nutrient uptake, 
morphology, motility, gene expression, intercellular communication, and control of cell 
homeostasis, among others. Many aspects of protein-protein interactions are necessary to 
understand how a protein carries out its functions. The amino acid sequence and its structure may 
be used to ascertain motifs that identify the likely function of a protein. Conserved sequences are 
especially important in revealing orthologous proteins from different organisms. Also, conserved 
sequences found in different organisms may help identify residues that are crucial to the 
regulation of protein function.  Expression profiles can explain the specificity of cell type and 
how expression is modulated within cells. Also, the function of proteins may be examined by 
how they are post-translationally modified or how they modify other proteins. Post-translational 
modifications may  regulate the activity of proteins, where they localize, and how they are 
activated (Protein-protein Interactions: a Molecular Cloning Manual 2005). Moreover, the 
localization of proteins may suggest the function of a protein or provide an understanding of the 
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proteins that a specific protein may interact with to help it carry out its function. Most 
importantly, the function of proteins can be elucidated by understanding their interactions with 
other proteins.  
 Protein-protein interactions appear in two forms, transient and stable. Stable interactions 
are characteristic of proteins that are involved in multi-subunit complexes, containing different 
or identical subunits. Proteins involved in stable interactions may help stabilize a complex of 
proteins. There may be many proteins interacting in a complex that centers around one protein. 
In a sense, different protein-protein interactions may help assemble a multi-subunit complex to 
strengthen the functions of specific proteins. Or proteins may interact with one another to 
regulate the catalytic activity of specific proteins.  
In contrast, transient protein interactions are believed to govern most cellular processes 
(Protein-protein Interactions: a Molecular Cloning Manual 2005). A transient interaction is an 
interaction that is temporary. Transient interactions are also known as unstable interactions, 
because unlike stable interactions, transient interactions occur rapidly and usually include an 
association of two proteins. Transient interactions regulate cellular processes including transport, 
folding, cell cycling, and protein modifications. Protein-protein interactions are essential to cell 
viability. In general, cells perform many functions that are necessary for the survival of the entire 
organism as a whole. Without protein-protein interactions, cells will not be able to perform the 
functions necessary for maintenance and regulation of an organism. Ultimately, a cell depends 
on both stable and transient interactions for the upkeep of an entire organism.  
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N
6
-methyl-adenosine (m
6
A) 
As explained, protein-protein interactions are important for the regulation of many 
cellular processes. One such process found in all organisms is mRNA methylation, an important 
posttranscriptional modification of adenosine residues known as N
6
-methyl-adenosine (m
6
A). As 
the most common modification of RNA molecules in eukaryotes, m
6
A  may serve as a 
significant, novel epigenetic marker in all organisms (Niu et al. 2013). The m
6
A modification is 
catalyzed by specific proteins known as Ime4 in Saccharomyces cerevisiae, Mettl3 in Homo 
sapiens, Dm Ime4 in Drosophila melanogaster, and MTA in Arabidopsis thaliana. These four 
proteins have been extensively researched in terms of how this modification affects transcript, 
protein, developmental, and metabolic functions (Jia, Fu, and He 2013).  The m
6
A modification 
seems to be evolutionarily conserved, and may function to regulate gametogenesis in eukaryotes 
(Clancy et al. 2002; Hongay and Orr-Weaver 2011). The Ime4 protein in yeast remains to be the 
most extensively studied and multiple Ime4 interacting proteins have been discovered.  
Saccharomyces cerevisiae interacts with its environment and receives a variety of 
nutritional and genetic signals to activate cellular developmental pathways including sporulation 
and mating. Through many very involved and intricate experiments, it was found that Ime4 
activated a variety of sporulation specific genes that ultimately lead to the formation of haploid 
spores through a specific modification of mRNA molecules (Shah and Clancy 1992). Once Ime4 
becomes active, it initiates a mechanism by which the catalytic motif IV catalyzes methylation of 
N
6
-adenosine residues (m
6
A) in polyadenylated mRNA within yeast cells that are sporulating 
(Clancy et al. 2002).  Modified targets may include mRNAs of IME1, IME2, NDT80, IME4 
itself, and other sporulation specific transcripts at particular adenosine residues (Bodi et al. 
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2010). The m
6
A modification may cause alterations of these mRNAs, in which lead to changes 
in stability, splicing, efficient translation, or compartmentalization (Clancy et al. 2002).  
In accord, Ime4 may be viewed as a meditator for the activation of these genes through 
this mechanism of methylating adenosine residues. Though the function of m
6
A is still 
unidentified, it may cause the aforementioned functions. Strong evidence, through methylation 
inhibitor experiments, indicates that the m
6
A modification may play a role in transcript splicing, 
stability, translation efficiency, or compartmentalization in mammalian cells. Unfortunately, the 
pleiotropic effects of these experiments cannot verify that m
6
A causes these transcripts to alter 
their biogenesis (Clancy et al. 2002). Through the discovery of proteins involved in the protein 
complex of Ime4, it may become clearer as to what function m
6
A coordinates. Two proteins have 
already been discovered to interact with Ime4, known as Mum2 and Slz1. This complex will be 
explained later in the Introduction.  The human ortholog of Ime4, MT-A70 (also referred to as 
METTL3), may also have similar roles to Ime4, and also functions in a protein complex.  
The m
6
A modification in humans is catalyzed by the MT-A70 subunit of a large protein 
complex. The catalytic Mettl3 subunit is the only one that has been identified to date. This 
catalysis by MT-A70 is believed to be involved in the regulation of many processes in humans 
including embryonic development, gonad development, mRNA metabolism, and protein 
expression (Niu et al. 2013). There is some evidence that the m
6
A modification may play a 
regulatory role in the nuclear export machinery (Niu et al. 2013). This has been observed in 
experiments that involve HeLa cells treated with the methylation inhibitor S-
Tubercidinylhomocysteine (STH), which showed that the retention time of mRNA in the nucleus 
increased by 40% on average (Camper et al. 1984). Remarkably, high m
6
A activity was detected 
in cells that underwent transformations as compared to non-transformed cells, indicating a 
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relationship between cancer and m
6
A methylation (Tuck et al. 1996). Though m
6
A may be 
involved in these processes, its exact function has yet to be elucidated. MT-A70 functions in a 
virtually unknown protein complex that is presumed to involve many specific protein-protein 
interactions. Discovering these protein-protein interactions in this unknown protein complex will 
be important in elucidating the functions of the m
6
A modification.  
 
 
Figure 1:  N
6
-Methyl-adenosine (m
6
A) 
 Saccharomyces cerevisiae as a model organism 
Saccharomyces cerevisiae is a model organism to study the cellular processes of 
eukaryotes.  Saccharomyces cerevisiae was the first eukaryote to have its genome sequenced 
(Botstein, Chervitz, and Cherry 1997).  This was an amazing feat because by having all of its 
genome decoded, scientists have used yeast as a model to study human diseases such as cancer, 
infections, and hereditary diseases.  Determining the function of yeast proteins is critical to 
understanding how human proteins function as well. The genome of yeast can be compared to 
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the human genome to assess the number of yeast genes that have noteworthy mammalian 
homologs (Botstein, Chervitz, and Cherry 1997). Yeast cells also share a common fundamental 
life cycle and cellular construction with more complex multicellular organisms, including 
humans and plants (Mell and Burgess 2002). Yeast may contain 31% of protein encoding genes 
that have robust mammalian homologous proteins (Botstein, Chervitz, and Cherry 1997).  This 
homology between yeast genes and human genes that encode functional proteins is the most 
important reason Saccharomyces cerevisiae is used as the model organism for experimental 
study. Yet, there are many more incentives to using yeast as a eukaryotic model organism for 
experimental study.  
Saccharomyces cerevisiae is in many ways analogous to the bacterial organisms scientist 
use to conduct experiments. Bacteria such as E.coli, are easy to manipulate and many E.coli 
strains are affordable for purchase. Yeast is similar to E.coli in this aspect, because yeast is also 
simple to manipulate and strains are also affordable (Botstein, Chervitz, and Cherry 1997). Also, 
segregation analysis and screening mutants are simpler to accomplish in yeast than in any other 
multicellular organism (Mell and Burgess 2002). Performing experiments on yeast, such as 
plasmid transformations, deletions, protein extractions and assays, mutagenesis of gene targets, 
and knock out of targeted genes is important for investigators because these methods help to 
identify functions of many different types of genes that may be similar to the human homolog of 
these genes. Also, by performing the aforementioned experiments on yeast, scientists may be 
able to solve complicated mechanisms of cellular pathways that are crucial for the understanding 
of human disease processes.  By using yeast as an experimental model, scientists are able to 
induce mutations in yeast genes (e.g. metabolic genes) to demonstrate the importance of these 
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genes in control of cellular pathways and regulations of cellular mechanisms (Mell and Burgess 
2002).  
Another incentive for using Saccharomyces cervisiae as an experimental model is that the 
time required to perform experiments on yeast is relatively short in comparison to multicellular 
organisms. A fundamental difference between using more complex eukaryotic models in 
comparison to yeast is the amount of time required to grow these organisms. The generation time 
is infinitesimal compared to the amount of time it would require to grow an organism such as a 
mouse for experimentation. Saccharomyces cervisiae has a generation time of about 90 minutes, 
and this is important when scientists need to observe rare events such as genetic mutations (Mell 
and Burgess 2002). Because the generation time is so short, many millions of cells can be 
cultured rapidly, and this increases the probability that a genetic mutation can be identified, with 
its effects testable.  For example, a mutagenesis experiment performed on yeast may require 
three days, which is short in comparison to doing mutagenesis experiments on mice which may 
require many months before a comprehensible result is obtained.  
Mating of Saccharomyces cerevisiae and its role in its life cycle 
Saccharomyces cerevisiae undergoes meiosis in nutrient-limiting environments. 
Specifically, meiosis is induced by media that lacks nitrogen but contains an adequate respirable 
carbon source, typically acetate. This is essential to the continued survival of yeast because they 
can undergo major physical transformations that allow them to pass on and assort their genetic 
information. Interestingly, yeasts are able to exist in both haploid and diploid forms. Glucose and 
nitrogen deprivation causes biochemical changes to occur in diploid yeast cells, and these 
alterations cause diploid yeast cells to change to their haploid forms through the process of 
meiosis and spore formation (Wagstaff, Klapholz, and Esposito 1982). In their haploid forms, 
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yeast cells express alleles that differentiate the mating types of yeast cells. Haploid cells can 
either be MATa or MATα, which are the alleles that phenotypically address the differences of 
the two different sexes in haploid yeast cells. The MATa and MATα alleles of the mating type 
locus regulate the expression of genes encoding pheromones known as ‘a pheromone’ and ‘α 
pheromone’ and other genes involved in cell fusion. Pheromones induce intracellular changes 
that cause the MATa and MATα cells to be attracted to one another, leading to the formation of 
cell projections and consequentially to the formation of morphological structures called schmoos 
(Bardwell 2004). Once the haploid cells fuse to one another, the nuclei also fuse causing the 16 
chromosome haploid to become a 32 chromosome diploid known as the MATa/MATα cell 
(Bardwell 2004). The resulting diploid does not mate, but can be propagated indefinitely 
mitotically. 
This mating process, in all, turns two haploid cells into a functional diploid cell which 
may then undergo the process of meiosis to form four distinct haploid cells. Two of the four 
haploid cells are MATa and the remaining two are MATα. This process is crucial to the survival 
of yeast in harsh environments. Also, meiosis creates genetic variations through the process of 
crossing over and exchange of genes from two distinct cells. This allows yeast to acquire gene 
combinations that are necessary for survival in harsh habitats. The meiotic process that yeast 
undergoes is very interesting. This same process occurs in higher eukaryotic organisms such as 
mammals, but not in the same way. Meiosis only occurs in gamete cells in animals, but 
identifying the genes that mediate meiosis in yeast may lead to a better understanding of how 
meiosis operates in animals. Research has unequivocally identified the discovery of genes that 
induce meiosis in Saccharomyces cerevisiae such as IME4, IME1, and IME2.  
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IME4 and its role in sporulation in Saccharomyces cerevisiae 
   The expression of key activators is essential for ascosporogenesis and meiosis in yeast. 
Meiosis and ascosporogenesis are complex processes involving the creation of genetic variation, 
production of many new proteins, and turnover of foregoing cellular constituents (Clancy et al. 
1983). “Early” genes such as IME1 and IME2 begin to be transcribed at about 1-2 hours in most 
laboratory strains following the nutritional deprivation of Saccharomyce cerevisiae and may 
decrease significantly thirteen hours following nutritional deprivation (Clancy et al. 1983). Some 
sporulation-specific mRNAs are synthesized at about 7 hours, such as NDT80, which encodes a 
transcription factor for genes involved in spore formation and exit from the pachytene stage of 
meiosis (Jia, Fu, and He 2013). Three genes known as IME4, IME1, and IME2 are essential early 
activators of meiosis in yeast. The activation of these genes is precisely regulated, and their 
activation is essential for meiosis and spore formation. Though the mechanism of activation is 
not fully understood, it is essential that these three genes, in lieu of the activation of other 
sporulation-specific genes, be active for a certain time during meiosis.  
 Ime4 plays a very important role in the induction of meiosis in yeast that are nutritionally 
deprived of nitrogen and that are placed on respirable carbon sources (Clancy et al. 2002). IME4 
is located on the left arm of chromosome VII in between ADE5 and LYS5 (Shah and Clancy 
1992). Its importance resides in the fact that it is finely regulated. IME4 is transcribed in low 
quantities during the diploid lifecycle of MATa/MATα vegetative yeast cells (Shah and Clancy 
1992). This is important because this transcript needs to be present in small quantities in order to 
activate sporulation-specific transcripts when yeast cells are starved of their required nutrients 
that maintain their viability. Ime4 is also known to methylate its own mRNA along with those of 
other genes known as IME1 and IME2, among others (Bodi et al. 2010). 
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 Ime1 is a transcriptional activator of meiosis, and leads to the transcription of genes that 
are required for sporulation (Kassir, Granot, and Simchen 1988). Ime1 induces a cascade of gene 
expression that regulates meiosis and sporulation under starved conditions (Bodi et al. 2010). 
Because of this cascade of gene activation, it is noted that more than five hundred new mRNA 
transcripts exist during yeast meiosis (Chu et al. 1998). This is important because yeast cells 
morph into entirely new cells and require different proteins to regulate this transformation. IME1 
mRNA is not present in high amounts during the vegetative mitotic life cycle of yeast, and thus, 
its regulation is dependent on other proteins (Shah and Clancy 1992). Its expression increases 
rapidly during conditions where yeast cells are starved, and it leads to the activation of the two 
genes encoding IME2 and NDT80 among many others that are needed for meiosis, 
recombination, and chromosomal segregation. 
Ime2 and Ndt80 play important roles in the regulation of meiosis. In order for sporulation 
to occur correctly, Ime1 and Ime4 need to be inactivated at certain times as cells transition into 
the meiotic process. In order for these proteins to be inactivated, they require the function of 
Ime2 and Ndt80, respectively. Ime2 is a serine/threonine protein kinase that mediates the 
stability of the Ime1 protein during meiosis, it is required for the degradation of Ime1, and also 
for the activation of Ndt80 (Guttmann-Raviv, Martin, and Kassir 2002). Ime2 itself is very 
unstable and is toxic in vegetative diploid yeast cells (Guttmann-Raviv, Martin, and Kassir 
2002). By degrading Ime1, Ime2 down regulates the activity of Ime1. Ime2 phosphorylates the 
C-terminal domain of Ime1, leading to its degradation by a 26S proteasome (Guttmann-Raviv, 
Martin, and Kassir 2002). The interaction between Ime1 and Ime2 may be viewed as a negative 
feedback loop. The activation of Ime1 causes activation of the Ime2 protein, and when the Ime2 
protein is active at a certain point, it causes the degradation of Ime1. Ime2 is likely to 
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phosphorylate other protein targets as well (Guttmann-Raviv, Martin, and Kassir 2002). Ndt80, 
on the other hand, is a meiosis-specific transcription factor that is essential for the progression of 
yeast cells through the pachytene stage of meiosis and is responsible for activating the “middle” 
group of sporulation specific genes (Xu et al. 1995). Ime4 may function to activate Ndt80, which 
in turn down regulates IME4 during the middle phase of meiosis (Agarwala et al. 2012). This 
may be achieved indirectly through the activation of Ime2, and/or directly by modification of 
adenosine residues of the Ndt80 transcript (Agarwala et al. 2012). This modification is an 
essential part of the Ime4 protein function. It functions to methylate the sporulation specific 
transcripts that are part of the meiosis cycle in yeast.  
The IME4 homolog, METTL3 
 The human ortholog of Ime4 is METTL3, also known as MT-A70. There is a 72% 
sequence similarity between Ime4 and METTL3 proteins (Bokar et al. 1997).  The METTL3 
protein is found in human cells. This is significant because the homologs perform the same 
function, which is to methylate mRNA transcripts. The entire protein complex consists of two 
separable components known as MT-A and MT-B (Bokar et al. 1997). The total weight of these 
components is 1075 kDa (200 kDa for MT-A and 875kDa for MT-B) as estimated by gel 
filtration chromatography (Bokar et al. 1997). MT-A and MT-B contain multiple subunits, and 
the subunit with catalytic activity is encoded by METTL3 (Bokar et al. 1997).  METTL3 is the 
gene that encodes the 70 kDa subunit of the human mRNA m
6
A MTase known as MT-A70, 
which is located in the protein component MT-A (Bokar et al. 1997). 
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Figure 2: Sequence Alignment of IME4 
The function of the catalytic subunit is to methylate adenosine residues on mRNA 
transcripts in humans, which is the exact function of Ime4 in yeast cells. This posttranscriptional 
modification is also known as m
6
A in humans. The only difference is Ime4 methylates adenosine 
residues on mRNA transcripts in yeast exhibiting sporulation. The function of m
6
A is still 
unknown, wherever it is found (Bokar et al. 1997).  Past experiments using HeLa cells have 
shown that decreased levels of m
6
A coincide with a decreased level of newly transcribed mRNA 
in the cytosol (Bokar et al. 1997). This finding suggests that this modification may play a role in 
regulating the transport of mRNA from the nucleus to the cytoplasm. Also, m
6
A may play a role 
in further posttranscriptional modifications. The evidence for this notion lies in inhibition 
experiments on HeLa cells with decreased m
6
A found on newly transcribed mRNA transcripts. It 
is shown that a decrease in the m
6
A modification results in aggregation of unspliced pre-mRNA 
in the nucleus (Bokar et al. 1997). The modification by MT-A70 may also play a role in mRNA 
metabolism.  
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 The system by which MT-A70 expression is regulated has yet to be elucidated. It may be 
regulated tissue specifically or developmentally, but research has yet to confirm this possibility 
(Bokar et al. 1997). Ime4 is regulated in a timely fashion and is only active in yeast cells during 
sporulation. Ime4 is also regulated by the decrease of antisense transcripts that is correlated with 
an increase of sense transcripts (Agarwala et al. 2012). It has been confirmed that when a cell 
undergoes a transformation of some sort, whether it is a viral infection or cellular transformation, 
the content of adenosine residues that are methylated increases substantially (Bokar et al. 1997). 
Transformations of adenovirus into rat embryonic cells resulted in a 7.5-fold increase in MT-A70 
activity (Bokar et al. 1997).  There may be a connection to the regulation of m
6
A modifications 
in humans, and in some way, this modification may change the fate of specific mRNA 
transcripts. More research should be done to understand this phenomenon.  
Mum2 and Slz1 in complex with Ime4 
 Ime4 is known to interact with other proteins in order to carry out its function, which is to 
methylate N
6
-adenosine residues on mRNA transcripts. This is a fairly new discovery, and these 
protein-protein interactions complement one another. This protein complex, defined by two 
hybrid analysis, contains Ime4, Mum2, and a protein known as Slz1 (known as theMIS 
complex). Kar4 has also been reported to be included in a complex involving Ime4 and Mum2 
(S. Morgan and J. Eugebrecht, Personal Communication). There is not much known about 
Mum2 and Slz1, but Mum2 was shown to be a crucial protein for the methyltransferase activity 
of Ime4 (Agarwala et al. 2012). Slz1 functions as an accessory protein to further enhance the 
catalytic activity of Ime4 (Agarwala et al. 2012).   
 Mum2 is a protein that is, at least partially, located in the cytoplasm, and it is necessary 
for sporulation in Saccharomyces cerevisiae (Davis et al. 2001a). Mum2 can be found in the 
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nucleus as well, where methylation of pre-mRNAs occurs in eukaryotic cells. Also, Mum2 
(Muddled Meiosis 2) interacts genetically with Orc2p, which is a protein that is part of the origin 
recognition complex (Davis et al. 2001b).  Mum2 is a protein with a coiled-coil region located at 
its C-terminus that may interact with Ime4 to form a scaffold where other proteins may bind and 
further strengthen the activity of the MIS complex (Davis et al. 2001b). Coiled-coil protein 
structures are formed by several alpha helical regions in complex with one another (Davis et al. 
2001b). Mum2 may also activate Ime4 to perform its catalytic activity, or Mum2 could function 
to target Ime4 to mRNA molecules (Agarwala et al. 2012). The importance of Mum2 was 
revealed in deletion experiments. When MUM2 was deleted, yeast cells attained sporulation 
defects similar to when IME4 was deleted in previous experiments (Agarwala et al. 2012). This 
verifies the significance of Mum2 in sporulation. Even more fascinating is when Ime4 is not in 
complex with Mum2, Ime4 cannot abundantly modify mRNA transcripts (Agarwala et al. 2012). 
The prominence of Mum2 in the MIS complex was verified through these elegant deletion and 
mutagenesis experiments. 
 Slz1, on the other hand, is a sporulation-specific transcription factor that contains a 
leucine zipper domain (Agarwala et al. 2012). There is not much known on the direct function of 
this protein, but it is a known component of the MIS complex. With its association in the MIS 
complex, it appears to strengthen the activity of Ime4 (Agarwala et al. 2012). Through SLZ1 
deletion experiments, it has been proven that Slz1 is not a critical component of the MIS 
complex (Agarwala et al. 2012). Ime4 is able to methylate adenosine residues in the absence of 
Slz1 when overexpressed in mitotic cells. Slz1 may be switched out with other transcription 
factors in the MIS complex, but experiments would have to be performed to confirm this 
possibility (Personal communication with Dr. Clancy).  
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Wt1 and Wtap 
Wt1 (Wilms’ tumor 1) and Wtap (Wilms’ tumor associated protein) are important 
proteins found in humans. These proteins regulate a variety of functions in the human body. 
These proteins interact with one another to carry out their functions. Defects in these proteins 
cause major health issues in young children and adults, such as Frasier syndrome, Denys-Drash 
syndrome, Wilms’ tumor (embryonal malignancy of the kidney), nephrotic syndrome type 4, 
Meacham syndrome, and mesothelioma malignancies (Weizmann Institute of Science 2012).  
Wtap and Wt1 proteins are known binding partners. The Wtap protein mostly interacts 
with Wt1 when a three amino acid sequence, KTS, is absent from the Wt1 protein sequence 
(Little, Hastie, and Davies 2000). Wtap is a protein that is ubiquitously located in the nucleus of 
human cells (Horiuchi et al. 2006). Interestingly, Wtap is important for the stabilization of 
mRNA transcripts that encode the protein cyclin A2, which is important for G2/M transition 
(Horiuchi et al. 2006). The knockdown of WTAP shows a substantial decrease in cyclin A2 
mRNA transcripts, and also causes death of 6.5 weeks old rat embryos (Horiuchi et al. 2006). 
Also, the knockdown of WTAP leads to an increased activation of cell adhesion, metabolism, and 
inflammation (Horiuchi et al. 2006).  The importance of this protein may therefore lie in its 
regulation of the cell cycle, and possibly the role it plays in its interaction to Wt1.  
Wtap has been proposed to be the human ortholog of the yeast protein Mum2, and this 
homology indicates that Wtap and Wt1 may be interacting in a larger unknown protein complex 
(Agarwala et al. 2012). A homolog of Wtap was also identified in Drosophila melanogaster, 
known as Fl(2)d. Fl(2)d is regarded as a splice factor that regulates the alternative splicing of the 
sex lethal (SX1) gene (Penn et al. 2008). The splicing of the SX1 gene by Fl(2)d is known to 
regulate female specific programs (Penn et al. 2008). Fl(2)d is also known to interact in a protein 
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complex as a splicing factor, and this indicated that the human Wtap protein may also interact as 
a splice factor in association with a protein complex. Wtap has been observed to associate in 
functional human spliceosomes, but how it contributes to the splicing process is a mystery (Penn 
et al. 2008).  More importantly, strengthening the notion that Wtap may interact in a protein 
complex with Mettl3, is the verification that the homolog of Mettl3, known as MT-A in 
Arabidopsis thaliana, interacts directly with a homolog of Wtap, known as At FIP37. Evidence 
for this is observed in coimmunoprecipation assays that show MT-A and At FIP37 directly 
interacting with one another (Zhong et al. 2008). Also, knockout experiments of either MT-A 
and At FIP37 resulted in inhibition of embryonic development at the globular stage in 
Arabidopsis thaliana (Zhong et al. 2008). These experiments reinforce the notion that Wtap may 
interact as a splicing protein, and that Wtap is, in fact, a protein that binds to Mettl3 to regulate 
its function and affect cell fate. The experiments to prove the Wtap protein is directly interacting 
with Mettl3 is still being carried out by our lab, but what is known is Wtap interacts directly with 
Wt1.  
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Figure 3: Sequence alignment of MUM2  
Wt1 is a protein that is involved in the development of the kidney and the reproductive 
organs (Little, Hastie, and Davies 2000). This protein is amazing because it may assume many 
functions. Wt1 protein is known to exist in 16 different isoforms (Little, Hastie, and Davies 
2000). Yet, how can one protein assume many different roles from a single, primary transcript? 
The gene that encodes WT1 may include different types of exons that can alter different 
segments of the translated protein. This is a posttranscriptional modification of the encoded WT1 
transcript. More specifically, WT1 has two alternating splice sites that encode different versions 
of the same protein. One splice site is encoded by exon 5, and if this site is included in the post 
modified transcript, it encodes a specific 17 amino acid sequence that may or may not be 
included in the final translated protein (Little, Hastie, and Davies 2000).  Though not much is 
known about the function of the 17 amino acid sequence, it may be a transcriptional repression 
domain (Natoli et al. 2002).   
 18  
 
The second alternatively spliced exon includes a lysine, threonine, and serine (KTS) 
consecutive sequence which is believed to inhibit the use of Wt1 as a DNA binding protein 
(Little, Hastie, and Davies 2000). This is because Wt1 has a zinc finger binding domain, which is 
used to bind DNA, that the KTS sequence hinders (Little, Hastie, and Davies 2000).  
Interestingly enough, many of the functions that Wt1 performs must incorporate the interaction 
of other proteins. Wt1 may also act as a transcription factor, but only if other proteins interact 
with Wt1 to allow it to carry out its function (Little, Hastie, and Davies 2000). Wt1 may also act 
as a posttranscriptional regulator, may play a role in splicing, and it may have a role in cell cycle 
regulation (Natoli et al. 2002). Through the use of yeast-two hybrid experiments, scientists have 
discovered that Wtap and Wt1 are definite binding partners (Little, Hastie, and Davies 2000). 
These proteins may also interact in an unknown protein complex. The importance of this 
interaction is still unknown.  
Protein complexes 
An explanation of protein complexes segues into the experimental approaches we have 
taken to understand how the MIS complex functions, and to discover new unknown proteins that 
may be associated with the MIS complex.  
 A protein complex is a single functional system consisting of multiple proteins that may 
assume different functions but all work to strengthen the activity of a central protein in the 
complex. The proteins that function as a single unit may interact transiently or stably. As 
mentioned, not much is known of the MIS protein complex. It is known that the proteins that 
function in this complex strengthen the function of Ime4, which methylates adenosine residues 
on pre-mRNA transcripts. Also, we believe that the homolog of Ime4, known as Mettl3, may 
function in a protein complex similar to the MIS complex. The homology between Ime4 and 
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Mettl3 strengthens this hypothesis. Also, we hypothesize that the homolog of Mum2 (Wtap) may 
be a binding partner in the proposed Mettl3 binding complex.  
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Materials and Methods 
Materials 
 Primers were designed in lab and sent to Integrated DNA Technologies for their 
synthesis. Strataprep plasmid miniprep kits (The catalog number for the kit is 400763), 
Strataprep PCR purification kits (The catalog number for the kit is 400771), XL1-Blue 
competent and subcloning competent cells used for Escherichia coli transformations, GAL4 
Two-Hybrid Phagemid Vector kits, and high fidelity Herculase II fusion Pfu polymerase used for 
PCR amplifications were purchased from Agilent/Stratagene Technologies. Most of the 
restriction enzymes, Taq polymerase, and their associated buffers were purchased from Promega. 
Some restriction enzymes, the T4 DNA Ligase, and their associated buffers were purchased from 
New England Biolabs.  
Media used for Transformations and Cell Cultures 
 For E. coli transformations and streakings, we used Luria broth (LB) media. This media 
was made using 1.5% agar (0.015 g/ml), 1% bacto-tryptone (0.01g/ml), 0.5% yeast extract 
(0.005 g/ml), 0.5% NaCl (0.005 g/ml), and adjusted to a pH of 7.5. Accordingly, antibiotic 
resistance was included in the media depending on the requirement of the specific plasmid that 
was used. The antibiotics used were either ampicillin (100 µg/ml) or chloramphenicol (30 
µg/ml). LB liquid media used for cultures include the aforementioned ingredients excluding the 
agar.  
 For yeast transformation and culture maintenance, a variety of media was used. Yeast 
extract peptone dextrose (YEPD) was used to streak and culture yeast colonies. This media 
included all the necessary supplements that yeast cells require for survival. Ingredients used to 
make this media include 1% yeast extract (0.01 g/ml), 2% peptone (0.02 g/ml), 2% dextrose 
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(0.02 g/ml) , and 2% agar (0.02 g/ml) for plating. Liquid YEPD requires the above mentioned 
ingredients excluding the agar.  
 Nutrient limiting media was used for plasmid selection of transformed yeast. This media 
is known as synthetic complete (SC) media. The ingredients used to create this media include 
10X Bacto-yeast nitrogen base (YNB) without amino acids (0.067 g/ml), 5X dropout mix (0.01 
g/ml) , 2% dextrose (0.02 g/ml), 2% bacto-agar (0.02 g/ml), and the supplemental amino acids 
which include: 5 mls leucine (10 mg/ml), 5mls tryptophan (10 mg/ml), 5 mls histidine (10 
mg/ml), 10 mls uracil (2 mg/ml), 5 mls adenine (4 mg/ml), 5 mls lysine (10 mg/ml), and 5 mls 
methionine (10 mg/ml). The synthetic dropout mix without YNB was purchased from U.S 
BioLogical and does not contain adenine, histidine, leucine, tryptophan, and uracil.  
Primer Construction 
 Primers were designed in lab and purchased from IDT according to the gene we were 
interested in amplifying for cloning or verification purposes. The amount of oligo we received 
from IDT was usually approximately 20 nmoles, and was delivered in the form of dry powder. 
Also, the oligos were desalted before they arrived. Forward and reverse primers were created by 
specific sequences found on the genes we used. The forward primer was a copy of the beginning 
of the gene to be amplified or the beginning of the section of the gene to be amplified (5’ end of 
the gene). The reverse primer needed to be copied from the end of the gene or specific region of 
the gene to be amplified. Then, the reverse primer needed to be complemented with its necessary 
bases, and was written in reverse. Primers used for cloning incorporated restriction sites that 
coincided with the restriction sites located on the vector to which the gene was ligated. Also, 
extra bases were added or removed to put the gene in frame with the GAL activation or the GAL 
binding domain encoded by the vector, so the incorrect protein was not translated when a yeast 
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two hybrid experiment was performed. We used the restriction sites on the ligated plasmid which 
verified a ligated gene was cloned to its correct vector. Restriction enzymes knicked the genes at 
the junction sites and dropped the gene from its vector. An agarose gel was used to view the 
restriction digested DNA.  
Primers used for cloning are shown in the table below: 
Gene or Gene 
Fragment  Identity 
Forward Primer Sequence 
5’→3’ 
Reverse Primer Sequence 
5’→3’ 
BUR2  TTTTTCTCGAGATGTCTGCTA
CATCTTCA 
TTTTGTCGACTTATATTTTAGG
TTTTTTGGCATCTGG 
IME4 1-600  TTTTGAATTCATGATTAACGA
TAAATCA 
TTTTGTCGACCTGAGCAAAAT
ATAGGTT 
IME4 1-316  TTTTGAATTCATGATTAACGA
TAAACTA 
TTTTGTCGACATGTGCGGAGC
AATTGCC 
IME4 231-600  TTTTGAATTCCACCCAGGATT
AATTGAGTGCATTCAA 
TTTTGTCGACTTACTGTGCAA
AATATAGGTTATTTAG 
IME4 131-225  TTTTGAATTCGATTCGGAAAA
AGACCAA 
TTTTGTCGACGGATATTTTGG
ACCATTG 
METTL3 1-302  TTTTCCCGGGGAATGTCGGAC
ACGTGGAGCTCTATC 
TTTTGTCGACCTATTGATAATT
CGTCTGAAGTGCAGC 
METTL3 273-580  TTTTGAATTCTGTGACTATGG
AACCAAGGAGGAG 
TTTTGTCGACCTATAAATTCTT
AGGTTTAGAGAT 
MUM2  TTTTTAGATCATATATGAATT
ACATGGCT 
TTTTTGTCGACTCAATTAGCA
ACGTCC 
pAD 745-765 AGGGATGTTTAATACCACTAC N/A 
pBD 816-836 GTGCGACATCATCATCGGAAG N/A 
WT1  TTTTGAATTCGAGAAGGGTTA
CAGCACGGTC 
TTTTGTCGACCTAAAGCGCCA
GCTGGAGTTTGGT 
WTAP  TTTTTGAATTCACCAACGAAG
AACCTCTTCCC 
AAAAGTCGACTTACAAAACTG
AACCCTGTACATT 
YGL036W  ATTTGGATCCATGCAGAAGTG
TGCTGGC 
ATTTGTCGACTTAATTGTTCTC
ATTTTCAAAGTC  
 
Plasmids purchased for cloning: 
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Plasmid Identity Accession #/ 
Manufacturer 
Plasmid Created by : Transformation 
Markers 
pAD-GAL4-2.1 vector AF033313.1/ 
Stratagene 
Stratagene LEU2, Amp
r
 
pBD-GAL4 Cam 
vector 
U46126.1/ Sratagene Stratagene TRP1,Cam
r
 
 
Plasmids created for transformations:  
Plasmid Identity Accession #/ 
Manufacturer 
Plasmid Created by : Transformation 
Markers 
BUR2-GAL4AD DAA09542.1/ Open 
Biosystems 
Jenisha Ghimire LEU2, Amp
r 
IME4 1-600- 
GAL4BD  
P41833.1/ Clancy Lab Sanjeev Dahal and 
Pinithi Perrera 
TRP1,Cam
r
  
IME4 1-316- 
GAL4BD 
P41833.1/ Clancy Lab Sanjeev Dahal and 
Pinithi Perrera  
TRP1,Cam
r
 
IME4 231-600- 
GAL4BD 
P41833.1/ Clancy Lab Mary Clancy TRP1,Cam
r
 
IME4 131-225- 
GAL4BD  
P41833.1/ Clancy Lab Sanjeev Dahal TRP1,Cam
r
 
METTL3 1-302- 
GAL4BD 
BC001650.2/ Clancy 
Lab 
Yazan Alqara TRP1,Cam
r
 
METTL3 273-580- 
GAL4BD 
BC001650.2/ Clancy 
Lab 
Yazan Alqara TRP1,Cam
r
 
MUM2-GAL4AD CAA85000.1/ Clancy 
Lab 
 
Mary Clancy LEU2, Amp
r
 
WT1- GAL4AD BC032861.2/ Clancy 
Lab 
Yazan Alqara LEU2, Amp
r
 
WTAP- GAL4AD/ 
WTAP- GAL4BD 
BC069192.1/ Clancy 
Lab 
Yazan Alqara/ Yazan 
Alqara 
LEU2 ,Amp
r
/ 
TRP1,Cam
r
 
YGL036W- GAL4AD P53185.1/ Clancy Lab Yazan Alqara and 
John Williamson 
LEU2, Amp
r
 
 
Strain used for Yeast Two Hybrid assays: 
Strain Genotype Reporter 
Gene 
Transformation 
markers 
YRG-2
a MATα ura352 his3-200 ade2-101 
lys2-801 trp1-901 leu2-3 112 
lacZ, HIS3 leu2, trp1, his3 
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gal4-542 gal80-538 
LYS2::UASGAL1-TATAGAL1-
HIS3 URA3::UASGAL4 17mers(x3)-
TATACYC1-lacZ 
(Table copied from GAL4 Two-Hybrid Phagemid Vector Kits Instruction manual) 
Restriction Digests 
Restriction digests were used for verification that a gene had been cloned correctly, and 
was used to create the ends of vectors and inserts for cloning purposes. A typical restriction 
digest consisted of a mixture of restriction enzymes, their associated buffers, and the DNA that 
was used for cloning or verification purposes, in a 20 microliter total volume. A reaction 
included 2 microliters of 10X enzyme buffer provided by the supplier for optimal activity of the 
restriction enzyme. If two restriction enzymes were used in one 20 microliter mixture then one 
buffer that optimized the activity of both enzymes was used. The amount of sterile water used 
was variable, depending on the amounts of DNA and enzyme used. Typically, 0.5-1 microliter of 
enzyme was used (about 10 units of enzyme per microliter). The amount of DNA used was about 
<1000ng of DNA, and the amount of water used was between 11 and 14 microliters. Reactions 
were incubated at 37 degrees Celsius for approximately one hour for optimal enzyme activity.  
Polymerase Chain Reaction 
 The PCR amplification technique was used to amplify specific genes from their vectors. 
First, the vector in which the gene is enclosed was linearized using the appropriate restriction 
enzyme. Second, a mixture was made that included the required polymerase (2 units of Pfu or 
Taq polymerase), its 5X associated buffer (10 microliters), forward and reverse primers for the 
gene of interest (50-100 pmol), deoxyribonucleotide triphosphates (200 µM of dNTPs), the DNA 
of interest (<1000 ng), and sterilized water to a total volume of 50 microliters. Finally, this 
mixture was put into the PCR machine at variable temperatures. For the first step (initial 
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denaturation) the mixture was heated to 95 degrees Celsius for 5 minutes. The second step is the 
first denaturation which was set for 95 degrees Celsius for a time between 15-40 seconds. The 
third step is the annealing step, which was set at 45-60 degrees Celsius for a time between 30-60 
seconds. The fourth step is the extension step, which was set at 60-72 degrees Celsius for a time 
that corresponded with the length of the DNA (2minutes/kb for Pfu and 1 minute/kb for Taq). 
The final step is the final extension step which was set at 72 degrees Celsius for 5 minutes. Steps 
2-4 were repeated for 30 cycles.  
PCR Purification 
Minicolumns were used to purify DNA following a PCR or restriction digest to be used 
for cloning purposes. This kit includes a microspin cup with a filter that retains DNA equal to or 
greater than 100 bp. Also the kit includes wash buffer and DNA binding solution. DNA obtained 
from PCR amplification or restriction digests were mixed with equal volumes of DNA binding 
solution. The DNA binding solution and DNA mixture was transferred into a filtered microspin 
cup that was centrifuged (14,000 rpm) for 30 seconds. This separated the DNA binding solution 
from the DNA of interest. 750 microliters of wash buffer mixed with ethanol was added to the 
microspin cup and centrifuged in a microfuge for a maximum of 30 seconds to separate the wash 
buffer from the DNA. Then 1X TE was added to the column and incubated for 5 minutes. The 
microspin cup was then centrifuged as above to elute the purified DNA.  
Plasmid Purification from E. coli 
 Transformed plasmids from E.coli competent cells were purified using Strataprep 
plasmid miniprep kits. We used the protocol that came with the miniprep kit. It includes solution 
1, solution 2, solution 3, wash buffer, microspin cups, and 2 ml receptacle tubes. These solutions 
were used to break the cells, in order to extract the plasmid DNA and then to bind the DNA. 
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After cell lysis and centrifugation for a maximum of 5 minutes, the supernatant was transferred 
to a plasmid purification column (microspin cup seated in a 2 ml receptacle tube). Once the 
supernatant was added to the column, it was centrifuged for a maximum of 30 seconds. This 
separated the solutions from the plasmid DNA. Wash buffer was then added and separated from 
the DNA in the filter column; this assured the DNA was purified. Finally, 1X TE was added to 
the filter column, and left to incubate for 5 minutes at room temperature. The purified plasmid 
DNA was eluted with 1X TE.  
Cloning procedure 
 Cloning is an experiment used to create a fusion protein by using an insert and a vector of 
choice. The cloning procedure requires many steps and is very involved. Many of the steps 
required involve the aforementioned methods, and since these methods were already explained in 
sections above, I have summarized the cloning procedure as much as possible. PCR 
amplification was required to obtain large quantities of insert that was used for the ligation. Once 
large quantities of insert were obtained, the DNA was purified as much as possible using the 
Strataprep PCR purification kit. Following the PCR purification, separate restriction digests were 
run on the amplified insert and on the vector in which the insert was ligated. The restriction 
digest was to ensure that the ends of the insert and vector were compatible and able to ligate to 
one another. After the restriction digest, another purification procedure (using the Strataprep 
PCR purification kit) was required to ensure that the vector and insert were purified. If any 
restriction enzymes remained in the insert or vector mixtures the ligation procedure was inhibited 
due to continuous cutting by the enzyme. To make sure no residual enzymes remained after the 
purification, the vector and insert were placed on the heating block at 65 degrees Celsius for 20 
minutes. This denatured any residual enzymes and deactivated its activity.  
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 After the vector and insert were placed on the heating block, a gel was run to verify the 
DNA had not vanished, and also guaranteed that the bands coincided with the correct number of 
base pairs that the vector and insert contained. Also, a gel was used to estimate the amounts of 
vector and insert used for the ligation procedure. Usually, while the gel ran, we used the 
nanodrop instrument to quantify the amount of DNA present in both the vector and insert 
mixture. The nanodrop instrument measured the absorbance of the DNA mixture at 260 nm and 
the determined amount of DNA in nanograms per microliter. With this data, we calculated the 
exact amount of DNA used in the ligation mixture. Also, if the correct bands were viewed on the 
gel, the ligation was not abandoned. If bands were not observed on the gel, it was a good 
indicator that the correct DNA was not present, and the cloning procedure was redone.  
 After calculating the amount of DNA, based on the data obtained from the nanodrop and 
gel analysis, the ligation was ready to be performed. The mixture contained a T4 DNA ligase, its 
10X associated buffer, vector, insert, and sterilized water. The total volume used for our ligations 
was 40 microliters. The amount of 10X T4 DNA ligase buffer used was 4 microliters, and the 
amount of other components used in a ligation mixture was usually variable. The amount of T4 
DNA ligase used was usually between 0.5 -1 microliter (400 units/µl).  The amount of water 
used depended on the calculated amount of vector and insert used. After the mixture was created, 
it was incubated at room temperature for one hour. After this incubation period, the mixture was 
doubly incubated in a Styrofoam box filled with water at room temperature and put in the 4 
degree Celsius fridge overnight. This is so the ligase had the opportunity to be active at many 
different temperatures because we were not sure of the temperature it reached its optimal 
activity.  Once this incubation period was over, the ligation mixture was used for E. coli 
transformations on the correct antibiotic media (depended on the antibiotic resistant marker 
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found on the associated vector) and we retrieved the correct ligated plasmid. We found the 
correctly ligated plasmid by culturing many colonies from the E. coli transformation, 
miniprepped the cultured colonies to purify the recombinant DNA, used a restriction digest to 
drop the insert from the vector, and ran the restriction digested DNA on a gel that verified that 
the insert had dropped from the vector.  
E. coli Transformation 
 E. coli transformations were done to produce sufficient plasmid DNA. These 
transformations were performed after cloning so cells procured the recombinant DNA and 
produced sufficient DNA used for future experiments. The colony was cultured and 
miniprepped, respectively. The transformation began by thawing XL1-Blue competent or sub-
cloning competent cells. The sub-cloning grade competent cells (Stratagene) were used for quick 
transformations, but ultimately led to less efficient acquisition of the recombinant plasmid. The 
super-competent E. coli cells more efficiently acquired the transforming DNA, but required 
longer incubation times and used β-mercaptoethanol. β-mercaptoethanol was shown to increase 
transformation efficiency.  I have explained the procedure for the sub-cloning competent cells for 
ease of understanding.  
 Once the cells were thawed, 50 microliters of cells were added to a 14 ml “Falcon” tube. 
After this, 0.1-50 ng of DNA was added to the 50 microliters of competent cells and incubated 
on ice for 20 minutes. Following the incubation period, the mixture was heat-pulsed for 45 
seconds in a water bath that was 42 degrees Celsius. The duration of the heat-pulse was critical. 
The tube was then incubated on ice for 2 minutes. Then 0.9 ml of SOC (1ml of liquid LB media, 
100 microliters of 2M MgSO4, and 200 microliters of 20% glucose) medium was added to the 
competent cells mixed with plasmid DNA. The SOC, sub-cloning competent cells, and 
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recombinant DNA mixture was incubated at 37 degrees Celsius for 30 minutes with shaking at 
about 200 rpm. Afterwards, the mixture was plated on solid LB media with the correct antibiotic 
according to the antibiotic marker the plasmid contained. Usually, 100-200 microliters were used 
for each LB plate. Incubation overnight at 37 degrees Celsius was required for appearance of 
colonies.  
Yeast Transformations 
 Yeast transformation experiments were used to transform plasmids into yeast that were 
obtained from E. coli transformations or bought directly from a manufacturer. The transformed 
plasmid contained an amino acid marker that yeast cells required for viability. Before the actual 
transformation began, yeast colonies were cultured in liquid YEPD (usually 5 mls) and incubated 
at 30 degrees Celsius overnight. The yeast culture was robust so the yeast transformation was 
efficient. Once the yeast culture was done incubating, it was diluted in 45 mls of liquid YEPD. 
This gave us a 1:10 dilution so the cells did not overgrow when transformed. The diluted yeast 
cells were incubated for 1-4 hours. Following the incubation, the yeast cells were centrifuged in 
a desktop centrifuge for 15 minutes, washed with 10 mls of sterile water, re-centrifuged, and 
centrifuged again in an ultra-centrifuge for 5 minutes at room temperature. The cells were then 
re-suspended in 1ml sterile water and transferred to a 1.5 ml microfuge tube.  
 The cells were centrifuged, and the supernatant was discarded. A 1X TE/LiOAc solution 
(1ml 10X TE pH 7.5, 1ml 1M lithium acetate and 8 mls sterile water) was made to resuspend the 
cells, and then the cells were centrifuged once again. The yeast cells were re-suspended in 0.25 
mls of 1X TE/LiOAc solution. Then, 50 microliters were transferred to a different microfuge 
tube in which 5 microliters of carrier DNA (10 mg/ml) and transforming DNA were added. After 
this, a polyethylene glycol solution (4 mls 50% PEG, 0.5 ml 10X TE, 0.5 ml 10X LiOAc, and 
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equilibrated to a pH of 7.5) was made and 300 microliters was added to the transformed and 
carrier DNA yeast mixture. The mixture was incubated at 30 degrees Celsius for one hour, and 
after, 40 microliters of DMSO was added to increase transformation efficiency. The mixture was 
then heat shocked at 42 degrees Celsius for 15 minutes. Then the cells were washed and 
centrifuged in 1X TE. The cells were then resuspended in 1ml of 1X TE and 200 microliters 
were plated on solid selective media according to the plasmid used. The plates incubated for 
about 3 days at 30 degrees Celsius, or until colonies were fully grown. This high efficiency yeast 
transformation was performed according to the Linda Hoskins/Hahn Lab protocol 
(http://labs.fhcrc.org/hahn/Methods/genetic_meth/dmso_yeast_transform.html).  
Yeast-Two Hybrid to Test for Protein Interactions 
 The Yeast-Two Hybrid analysis is used to test for protein interactions (Molecular Cell 
Biology 2000). Two specific plasmids were used for this experiment. The pAD-GAL4-2.1 vector 
contains an ampicillin resistance marker for E. coli transformations, the LEU2 gene for selection 
in yeast transformations, and DNA encoding the activation domain of GAL4 for protein 
interaction. The pBD-GAL4 Cam vector contains a chloramphenicol resistance marker, TRP1 
gene for selection, and DNA encoding the binding domain for protein interactions. Both 
plasmids contain a multiple cloning site where several restriction sites are found for cloning 
purposes.  Before these plasmids were used for any transformation, the gene of interest (insert) 
was first ligated into these vectors, according to the cloning procedures previously explained. 
Then these recombinant plasmids were transformed into E. coli for overexpression of the 
plasmids, as explained in the E.coli transformation section. After the E. coli transformation, the 
plasmids were miniprepped and used for yeast transformations (as explained in the sections 
above).  
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 The recombinant plasmids were transformed into the YRG-2 yeast strain, which contains 
HIS3 and the Lac Z reporter gene driven by GAL4 binding sites to assess verified in vivo protein 
interactions. Also, the YRG-2 strain carries a mutation which ensures that the GAL4 gene is not 
expressed. Similarly, the YRG-2 strain carries leucine and tryptophan auxotrophic markers to 
verify that the GAL AD and the GAL BD recombinant vectors are transformed into the YRG-2 
strain. The YRG-2 strain also has a histidine auxotrophic marker to select for in vivo protein 
interactions. The HIS3 gene is only activated if the fusion proteins interact with one another. The 
Lac Z assay may also be used to test for protein interactions quantitatively.  
 The GAL AD and the GAL BD vectors were transformed simultaneously using the yeast 
transformation procedure explained in the previous section. To verify these plasmids were 
correctly transformed, the transformed cells were plated on SC solid media plates that did not 
contain leucine and tryptophan. Growth indicated that the cells contained the correct GAL AD 
and GAL BD vectors. These vectors should also contain the correct inserts which were translated 
in yeast cells to their protein products. The yeast cells that grew on the -leu,-trp plates were then 
patched onto SC plates that did not contain leucine, tryptophan, or histidine. If the cells grew on 
these plates, there was a protein interaction occurring. This experiment was done multiple times 
to acquire my results and to verify the results as well.  
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Results 
Cloning the IME4 gene and its fragments to test for specific protein-protein interactions 
The IME4 full length (amino acids 1-600) gene, the IME4 N- terminal (amino acids 1-
316) fragment, the IME4 C-terminal (amino acids 231-600), and the IME4 leucine (amino acids 
131-225) rich fragment were cloned into the GAL 4 binding domain of plasmid pBD-GAL4 Cam 
using the EcoRI and SalI restriction sites located on the GAL 4 binding domain vector to test for 
protein interactions. The IME4 gene and its aforementioned fragments were amplified using 
primers (see Materials and Methods section for specific sequence of primers) that contained 
EcoRI and SalI restriction sites that were used to ligate these inserts to the restricted vector, 
which contained the compatible sites as well. The purified PCR products were ligated to the 
pBD-GAL4 Cam vector to create in-frame protein fusions to the Gal 4 binding domain.  
 
 
 
 
 
 
 
Figure 4: A representation of the fragmented inserts of IME4 within the GAL4 binding domain.  
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Test for Auto activation of IME4 and its associated fragments 
 The N-terminal Ime4 fragment was seen to auto activate when transformed into YRG-2 
yeast strains with the empty pAD-GAL4-2.1 vector for yeast two hybrid assays. The empty pBD-
GAL4 Cam vector, full length, leucine rich, and catalytic regions of Ime4 did not auto activate 
when transformed with the empty pAD-GAL4-2.1 vector. By this notion, we did not use the 
Ime4 N-terminal in the yeast two hybrid assays because it would have given us false positives for 
any pAD-GAL4-2.1 vector with its associated insert. Also, we strongly believe that the HIS3 
reporter gene is leaky in certain transformations and has resulted in the slight increase of growth 
in the YRG-2 strain when transformed with Ime4 full length and an empty activation domain 
vector. We sequenced these bait plasmids and verified that all of them were correctly cloned and 
in frame. The reason the IME4 insert is used in the “bait” plasmid (binding domain) is because 
we are interested in validating novel protein interactions.  
 
a b c 
d e 
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Figure 5: a. pAD-GAL4-2.1 transformed with pBD-GAL4 Cam vector. b. Ime4 N-terminal (1-
316) in pBD-GAL4 Cam transformed with empty pAD-GAL4-2.1. c. Ime4 Full (1-600) in pAD-
GAL4-2.1 vector transformed with pBD-GAL4 Cam. d. Ime4 Catalytic region (231-600) e. Ime4 
Leucine rich region (131-225) in pBD-GAL4 Cam transformed with pAD-GAL4-2.1. 
 
Motivation to study Mum2 protein interactions 
 Mum2 and Ime4 were verified to interact with one another in a protein complex by the 
Fink Lab (Agarwala et al. 2012).  This protein complex is referred to as the MIS complex 
(Mum2, Ime4, and Slz). Mum2 is an essential protein in the MIS complex, and its interaction 
with Ime4 is crucial for Ime4 to carry out its catalysis. Deletion experiments of the MUM2 gene 
resulted in sporulation defects in Saccharomyces cerevisiae because of the consequent down 
regulation of Ime4 (Agarwala et al. 2012). Mum2 is essential for the catalytic activity of Ime4. 
We were interested in understanding the exact location of Mum2 binding with the Ime4 protein, 
and we used the fragments of IME4 to ascertain the sequence to which Mum2 binds to Ime4.  
Cloning the MUM2 gene 
 The MUM2 gene was cloned into the GAL4 activation domain (AD) vector as the “prey” 
protein and we assessed its specific interaction with the IME4 gene and its fragments, which 
were considered the bait “proteins” in yeast two hybrid experiments. The restriction sites used in 
the PCR amplification of the MUM2 gene were EcoRI and a BamI/BglII junction. The 
BamI/BglII junction was used because ligating the MUM2 gene into the GAL 4 activation 
domain proved to be difficult with the use of other restriction sites.  
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Figure 6: A restriction digest was performed on MUM2 in its GAL4 activation domain vector 
which showed that MUM2 was correctly ligated. Also, restriction digests were performed on 
IME4 and its associated fragments that were ligated to the GAL4 binding domain. The GAL 
binding domain vector is 6.5 kb, the GAL4 activation domain vector is 7.0 kb, the MUM2 insert 
is 1.1 kb, the IME4 full length insert is 1.8 kb, the IME4 N-terminal is 0.95 kb, the IME4 
catalytic region is 1.1 kb, and the IME4 Leucine rich segment is 0.28 kb. Also, we sequenced the 
fusion plasmid and verified the clone was in frame.  
 
Mum2 and Ime4 Protein-Protein interactions  
By using the yeast two hybrid assays, the cloned MUM2-GAL 4 activation domain and 
the IME4 full length-GAL 4 binding domain, with its fragments as well, were simultaneously 
transformed into YRG-2 yeast cells and plated on SC media that were lacking leucine and 
tryptophan to select for the two plasmids. The yeast cells present on the leucine and tryptophan 
deficient SC media grew for about three days before being patched onto leucine, tryptophan, and 
histidine deficient media to observe activation of the Gal 4 dependent HIS3 reporter in the strain. 
We patched the yeast cells on this media and verified that Mum2 and Ime4 full interacted. We 
further investigated the interaction between Ime4 and Mum2.   
Analogous experiments were completed with the Ime4 fragmented proteins and the 
Mum2 protein. We demonstrated that the Ime4 catalytic region (amino acids 231-600) did not 
 
Lane 1 MUM2 AD 
Lane 2 GAL AD (control) 
Lane 3 IME4 full 1-600 
Lane 4 IME4 N-terminal 1-
316 
Lane 5 IME4 231-600 
Lane 6 IME4 Leu 131-225 
Lane 7 GAL BD (control) 
Lane 8 LADDER 
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interact with the full length Mum 2 protein. The Ime4 N-terminal (amino acids 1-316) displayed 
an interaction with Mum2, but this result remains inconclusive because we validated that the N-
terminal domain of Ime4 is auto activated in yeast two hybrid assays. We zoomed in on a leucine 
rich region located in the N-terminal of the Ime4 protein, which did not auto-activate in previous 
yeast two hybrid experiments. We termed this region the Ime4 leucine rich region, extending 
from amino acids 131-225 of the Ime4 protein. Interestingly, Mum2 interacted directly with the 
Ime4 Leucine rich region in yeast two hybrid assays. This led us to believe that the interaction 
between Mum2 and the Ime4 Leucine rich region may be even more specific. Presently, we are 
conducting experiments that will narrow down the interaction between Mum2 and the Ime4 
leucine rich region.  
Motivation to study Ygl036w protein interactions 
Previous affinity capture and yeast two hybrid experiments have suggested that Ygl036w 
and Mum2 exhibit protein-protein interactions (TylersLab.com 2013). YGL036W is not an 
essential gene, and its function is unknown (TylersLab.com 2013). These interactions have 
implications that Ygl036w may interact with Ime4. 
Cloning the YGL036W gene 
 The YGL036W gene was cloned into the GAL4 activation domain vector using BamHI 
and SalI restriction sites that were incorporated into the primers. The YGL036W-GAL4 
activation domain fusion protein was transformed into YRG-2 yeast cells simultaneously with 
the IME4 full length and fragments of IME4 that were cloned into the GAL4 binding domain 
vector as above. This was done to investigate the interaction between Ygl036w and the Ime4 
protein, including its associated fragments.  
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Figure 7: A restriction digest was performed on YGL036W in its GAL4 activation domain vector 
which showed that YGL036W was correctly ligated. Also, restriction digests were performed on 
IME4 and its associated fragments that were ligated to the GAL4 binding domain. The GAL 
binding domain vector is 6.5 kb, the GAL4 activation domain vector is 7.0 kb, the YGL036W 
insert is about 2.7 kb, the IME4 full length insert is 1.8 kb, the IME4 N-terminal is 0.95 kb, the 
IME4 catalytic region is 1.1 kb, and the IME4 Leucine rich segment is 0.28 kb. Also, we 
sequenced the fusion plasmid and verified the clone was in frame. 
 
Ygl036w and Ime4 Protein-Protein interactions 
 Though virtually nothing is known about the Ygl036w protein, we decided to test 
whether or not Ime4 interacts with this protein. We were able to confirm that the full length Ime4 
protein does interact with the Ygl036w protein.  
 In discovering that the Ime4 full length protein and the Ygl036w protein interacted, we 
decided to do similar experiments that were done with the Mum2 protein, which narrowed down 
the interaction between Ime4 and Mum2 to specific leucine residues. The Ime4 catalytic region 
displayed no interaction with Ygl036w, and this result was consistent with those seen for all 
“prey” proteins. We then decided to test whether the leucine rich region of Ime4 interacted with 
Ygl036w, which Mum2 was verified to interact with. This experiment was inconclusive because 
  
Lane 1 YGL036W AD 
Lane 2 GAL AD 
(control) 
Lane 3 IME4 full 1-600 
Lane 4 IME4 N-
terminal 1-316 
Lane 5 IME4 231-600 
Lane 6 GAL BD 
(control) 
Lane 7 LADDER 
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it interacted very weakly with the Ime4 leucine rich region. We believed that the HIS3 reporter 
gene in the YRG-2 strain could be leaky when yeast two hybrid assay experiments are carried 
out. Further experimentation will be done to assess the results between the leucine rich region of 
Ime4 and Ygl036w. 
 
Figure 8: a. Ygl036w in the pAD-GAL4-2.1 vector transformed with Ime4 Full in the pBD-
GAL4 Cam vector. b. Ygl036w in the pAD-GAL4-2.1 vector transformed with empty pBD-
GAL4 Cam vector.  
 
Motivation to study Bur2 protein interactions 
 Bur2 is a cyclin for the Sgvp1 (Bur1) protein kinase, and they comprise a CDK-cyclin 
complex that is involved in transcriptional regulation (Yao, Neiman, and Prelich 2000).  The 
regulation of transcription through this complex is controlled by phosphorylation of the carboxy-
terminal domain of the largest subunit of RNA polymerase II (Yao, Neiman, and Prelich 2000). 
Fascinatingly, Bur2 used as the bait protein in yeast two hybrid analysis and Ime4 used as the 
prey protein was found to interact in two independent studies (Malmström et al. 2007).  The 
function of this interaction is still unclear, and it was in our best interest to find out the specific 
interaction between these two proteins. This may further elucidate the function of Bur2 in the 
MIS complex.  
a b 
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Cloning the BUR2 gene 
 The BUR2 gene was cloned using restriction sequences that were added to the specific 
BUR2 primer sequences. The restriction sequences are SalI and XhoI. We amplified this gene 
using the specific forward and reverse primers and cloned the insert into the GAL4 activation 
domain vector, which had compatible restriction sites.  
 
 
 
 
 
 
 
Figure 9: A restriction digest was performed on BUR2 in its GAL4 activation domain vector 
which showed that BUR2 was correctly ligated. Also, restriction digests were performed on 
IME4 and its associated fragments that were ligated to the GAL4 binding domain. The GAL 
binding domain vector is 6.5 kb, the GAL4 activation domain vector is 7.0 kb, the BUR2 insert is 
about 1.2 kb, the IME4 full length insert is 1.8 kb, the IME4 N-terminal is 0.95 kb, the IME4 
catalytic region is 1.1 kb, and the IME4 Leucine rich segment is 0.28 kb. Also, we sequenced the 
fusion plasmid and verified the clone was in frame. 
 
Bur2 and Ime4 protein-protein interactions 
 Yeast two hybrid screens were prepared to test the interaction between the Ime4 full 
length protein and the Bur2 protein. We used Bur2 as the prey protein and Ime4 as the bait 
 
 
 
Lane 1 BUR2 AD 
Lane 2 GAL AD (control) 
Lane 3 IME4 full 1-600 
Lane 4 IME4 N-terminal 
1-316 
Lane 5 IME4 231-600 
Lane 6 GAL BD (control) 
Lane 7 LADDER 
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protein in our yeast two hybrid assays, which opposed the two independent previous 
experiments. Our results were similar; we found that the Bur2 protein and the Ime4 full length 
protein interacted. We replicated the Ygl036w experiments to acquire a clearer representation of 
the specific interaction between Bur2 and Ime4. 
 Bur2 and the catalytic region of Ime4 were screened for interactions. We discovered that 
Bur2 and the Ime4 catalytic region did not interact when coupled in yeast two hybrid screens. 
The catalytic region of Ime4 seems to be absent of protein binding. This is why we are convinced 
that all the aforementioned proteins interact in the N-terminal portion of Ime4. To further 
convince us that Bur2 does not interact in a similar manner to Mum2, we tested the interaction 
between Bur2 and the leucine rich region of Ime4. These fusion proteins did not interact with 
one another in our yeast two hybrid screens.  
 
Figure 10:  a. Bur 2 in the pAD-GAL4-2.1 vector transformed with Ime4 Full in the pBD-GAL4 
Cam vector. b. Bur 2 in the pAD-GAL4-2.1 vector transformed with empty pBD-GAL4 Cam 
vector. 
Cloning the METTL3 gene and its fragments to test for specific protein-protein interactions 
 We tried numerous times to clone the full length METTL3 gene, but it proved to be 
difficult. We tried many different restriction sites in association with the restriction sites found in 
the GAL4 binding domain, but nothing seemed to work. We considered that the fusion protein of 
a b 
 41  
 
the full length Mettl3 protein could be toxic in E.coli cells when transformed following a ligation 
(Personal Communication with Dr.Clancy). But even this conclusion could be debated because 
the ligations could have been erroneous in some manner (Personal Communication with 
Dr.Clancy). We decided the best scenario would be to clone half segments of the protein to test 
for interactions using the yeast two hybrid screens.  
 METTL3 amino acids 273-580 was cloned into the pBD-GAL4 Cam vector using EcoRI 
and SalI restriction sites that were compatible with restriction sites situated in the multiple 
cloning site of the GAL4 binding domain vector. The primers (specific primer sequences can be 
viewed in the Methods section) contained the restriction sequences that were needed to create the 
flanking restriction sites for the METTL3 273-580 insert. The METTL3 fragment was cloned into 
the pBD-GAL4 Cam vector known as the bait plasmid because we were interested in observing 
its interaction with different proteins. The genes we used to test protein interactions with Mettl3 
were cloned into the pAD-GAL4-2.1 vector, which is considered the “prey” plasmid. 
Motivation to study Wtap protein interactions 
 We postulated that the Wtap protein would interact with the Mettl3 protein because of 
their orthology to the yeast proteins Mum2 and Ime4, respectively. Furthermore, Mettl3 has been 
suggested to carry out its catalysis in a protein complex (Bokar et al. 1997). The elucidations of 
the proteins that interact in the Mettl3 complex are still being investigated.  
Cloning the WTAP Gene 
 The WTAP gene was cloned into both the GAL4 activation and binding domain vectors. 
The restriction sites flanking the WTAP inserts were EcoRI and SalI. Only one pair of forward 
and reverse primers (specific sequences found in Materials and Methods section) with these 
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restriction sequences were required to successfully clone the WTAP inserts into their respective 
vectors. Once cloned, these plasmids were used for yeast two hybrid screens.   
 
 
 
 
 
Figure 11: A restriction digest was performed on WTAP in its GAL4 activation domain vector 
which showed that WTAP was correctly ligated. Also, restriction digests were performed on 
IME4 and its associated fragments that were ligated to the GAL4 binding domain. The GAL 
binding domain vector is 6.5 kb, the GAL4 activation domain vector is 7.0 kb, the WTAP insert 
is about 1.2 kb, and the IME4 N-terminal is 0.95 kb Also, we sequenced the fusion plasmid and 
verified the clone was in frame. 
 
Wtap protein interacting with itself 
 We did experiments that showed Wtap interacting with itself. The WTAP gene was 
cloned into the binding and activation domain plasmids, and then we transformed the plasmids 
simultaneously into the YRG-2 yeast strains. We then did a yeast two hybrid assay and 
discovered that Wtap does interact with itself. Also we did controls to verify that Wtap did not 
auto-activate. The results are shown in Figure 12.  
 
 
 
Lane 1 WTAP AD 
Lane 2 GAL AD 
(control) 
Lane 3 IME4 N-
terminal 
1-316 
Lane 4 GAL BD 
(control) 
Lane 5 LADDER 
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Figure 12: a. Wtap in the pBD-GAL4 Cam vector transformed with Wtap in the pAD-GAL4-2.1 
vector to test for their interaction. b. Wtap in the pAD-GAL4-2.1vector transformed with empty 
pAD-GAL4-2.1 vector as a control to ensure that it did not auto-activate. c. Wtap in the pAD-
GAL4-2.1vector transformed with empty pBD-GAL4 as a control to ensure that it did not auto-
activate.  
Wtap and Mettl3 273-580 protein interaction 
 Experiments were performed to test the interaction between Mettl3 amino acids 273-580 
and Wtap in the pAD-GAL4-2.1vector. We suspect that these proteins are interacting because of 
the growth on the plates shown in Figure 13. These protein interactions will have to be verified 
using coimmunopercipitation assays. 
 
Figure 13: a. Mettl3 amino acids 273-580 in the GAL binding domain (nicknamed “Bokar” by 
our lab) was shown to interact with Wtap in the GAL activation domain. b. Wtap in the 
a b c 
a b c 
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activation domain was transformed with empty GAL binding domain to ensure that it did not 
auto-activate. c. Mettl3 amino acids 273-580 in the GAL binding domain was transformed with 
GAL activation domain to make sure that Mettl3 amino acids 273-580 did not auto-activate. 
  
Motivation to study Wt1 protein interactions 
 Wtap has been verified to be a binding partner of Wt1 in yeast two hybrid assays (Little, 
Hastie, and Davies 2000). We tested the interaction between Wtap and Wt1 as a positive control. 
Furthermore, we were interested in discerning the interaction betweenWt1 and Mettl3.  
Cloning the WT1 gene 
 The WT1 gene was ligated using EcoRI and SalI restriction sites, which flanked the WT1 
insert. A PCR amplification using specific primers (primer sequence found in Materials section) 
contained the restriction sites that flanked the insert. The insert had the same restriction sites that 
its associated vector had so there were no compatibility issues. The vector was the GAL4 
activation domain, which had the same restriction sites necessary for an efficacious ligation.  
Wt1 and Wtap protein-protein interaction 
 We performed a yeast two hybrid assay to test the interaction between Wt1 in the pAD-
GAL4-2.1 vector and Wtap in the pBD-GAL4 Cam vector. Interestingly, these proteins did not 
interact in the assays we performed. We also did a Wtap binding domain and empty Gal-4 
activation domain plasmid control, and we did not see an interaction. Furthermore, we did a 
control of Wt1 in the Gal-4 activation domain vector and transformed it with empty Gal-4 
binding domain control, and we they did not interact. The absence of an interaction is most likely 
due to the Wt1 isoform we used to test this interaction.  
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Wt1 and Mettl3 273-580 protein-protein interaction 
 Utilizing the yeast two hybrid assays, we assessed the interaction between Wt1 in the 
Gal-4 activation domain vector and the fragmented Mettl3 273-580 protein which was cloned 
into the Gal-4 binding domain vector. We did not observe an interaction between these proteins 
in our assays. We also verified that these proteins did not auto-activate by transforming them 
with empty vectors. Wt1 in the Gal-4 activation domain vector was transformed with empty Gal-
4 binding domain plasmid, and no interaction was observed in this experiment. Mettl3 273-580 
in its binding domain vector was transformed with empty Gal-4 activation domain plasmid, and 
this protein did not auto-activate in our assays.  
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Discussion 
Protein complexes govern many processes that occur within cells. Discerning the proteins 
that regulate protein complexes is crucial to understanding the function of these proteins, and the 
function of the protein complex in its entirety. The N
6
-methyladenosine (m
6
A) modification is 
known to be regulated by a protein complex.  The role of the m
6
A modification is still unclear, 
but this modification is incredibly significant. It is unlikely that there is one unifying role behind 
this modification, but it may play many roles in cellular processes such as effecting 
transcriptional fate and regulation, mRNA metabolism, translational efficiency and control, 
protein transport, and regulating cellular transformations. m
6
A is the most prevalent internal 
messenger RNA modification detected in eukaryotes and in RNA of nuclear replicating 
organisms (Fine-tuning of RNA Functions by Modification and Editing 2005). The m
6
A 
modification is catalyzed by methyltransferases found in all organisms (e.g. Ime4 in yeast and 
Mettl3 in humans). These methltransferases are recognized to be in complex with other proteins 
that may regulate, enhance, or repress the catalysis of these methyltransferases. Understanding 
the exact function of m
6
A through experiments which directly invoke an alteration in this 
modification is perplexing, which is shown by many pleiotropic methlylation inhibitor 
experiments. It appears more fathomable to elucidate the function or functions of m
6
A by 
illuminating the protein-protein interactions that are associated in the protein complex that 
catalyzes this modification.  
 Ime4 in yeast catalyzes the methylation of pre-mRNA transcripts. Ime4 was hypothesized 
to reside in a protein complex that facilitated its catalysis, which is to transfer reactive methyl 
groups bound to sulfur in S-adenosyl methionine (SAM). It has since been verified that Ime4 is 
in complex with two proteins known as Mum2 and Slz1. Mum2 is known to be an essential 
 47  
 
protein in the Mum2-Ime4-Slz1 (MIS) complex. Our results show that Mum2 interacted in the 
amino acid region 131 through 225 within the N-terminal region of Ime4, which we considered 
the leucine rich region.  In this thesis, we have hypothesized that Mum2 may scaffold other 
proteins to this complex. The leucine region of Ime4 contains alpha helices that may bind the 
Mum2 coiled-coil protein.  
 Mum2 was verified to interact with Ygl036w in two independent experiments, which 
were affinity capture and yeast two hybrid assays. With this information, we tested whether 
Ygl036w would interact directly with the full length protein (amino acids 1-600) and its 
fragments. We observed that Ygl036w interacted with the full length Ime4 protein. We were also 
convinced that Ygl036w specifically interacted within the N-terminal region of Ime4, but 
experiments to confirm this are still ongoing because we established that the N-terminal 
fragment of Ime4 self-activated in yeast two hybrid screens. Also, we observed that Ygl036w 
does not interact in the catalytic region of Ime4 (amino acids 231-600) or the leucine rich region 
of Ime4. Similar results were shown with the Bur2 protein. The Bur2 protein interacted with the 
full length Ime4 protein, but does not interact with the leucine rich or catalytic region of Ime4. 
Experiments are still partial in concluding whether Bur2 interacts in the N-terminal of Ime4 
because of its difficult screening due to the N-terminal self-activating in yeast two hybrid 
experiments. We do not know the importance of these interactions with Ime4. We will be 
conducting gene deletion experiments to assess whether these interactions play a role in yeast 
cell viability or the sporulation process. We hypothesize that Bur2 may, in some manner, target 
Ime4 to RNA transcripts because of its interaction with RNA polymerase. Nothing can be said 
about Ygl036w and its interaction with Ime4 because there is virtually nothing known about this 
protein.  
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The human homolog of Ime4 is termed Mettl3, which is hypothesized to reside in an 
enormous protein complex. However, to our knowledge, the proteins that interact in this complex 
remain elusive. Mettl3 catalyzes the same function that Ime4 catalyzes, which is to methylate 
adenosine residues of mRNA transcripts internally. The mechanism by which this occurs is still 
unclear, and the proteins that regulate this modification catalyzed by Mettl3 are still unknown. 
Mettl3 amino acids 273-580 in the GAL binding domain was suspected to interact with Wtap in 
the GAL activation domain in our yeast two hybrid assays. We will need to perform future pull 
down assays to confirm this interaction. Wtap may act in a similar manner to Mum2, which is 
hypothesized to scaffold proteins to the Ime4 complex. Or Wtap may act as a splicing factor and 
affect the fate of methylated transcripts. Experiments are ongoing to elucidate these hypotheses. 
Also, it is necessary to make the connection that Wtap associates with the Wilms’ tumor protein 
1 (Wt1), which has an essential role in the normal development of the urogenital system. Mettl3 
may play a regulatory role in the function of Wt1 if it is found to interact with either Wt1 or 
Wtap.  
 Importantly, the m
6
A modification has remained evolutionarily conserved in all 
organisms over time. This is significant because natural selection conserved the genes that 
function to catalyze this modification. This conservation proves necessary for organisms to 
sustain their continued survival overtime. The most studied proteins that catalyze the m
6
A 
modification include Saccharomyces Cerevisiae, Homo sapiens, Arabidopsis thaliana, and 
Drosophila melanogaster. These proteins are termed Ime4, Mettl3, Mta, and Dm Ime4 
respectively. Deficiency experiments have revealed the importance of these proteins. Induced 
experimental deficiency of Mettl3 is detrimental and leads to apoptosis in Homo sapiens (Fine-
tuning of RNA Functions by Modification and Editing 2005). Developmental arrest was observed 
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in Arabidopsis thaliana when Mta was inhibited of its activity (Zhong et al. 2008). Defects in 
gametogenesis were verified when Ime4 and Dm Ime4 were silenced in Saccharomyces 
Cerevisiae and Drosophila melanogaster, respectively(Clancy et al. 2002; Hongay and Orr-
Weaver 2011). Discovering the exact function or functions of m
6
A and the proteins that interact 
in these complexes that catalyze this modification may prove to be medically relevant.  
 In Homo sapiens, experiments have revealed that the knockdown of Mettl3 resulted in 
apoptosis of Hep2G cells (Dominissini et al. 2012). Cells undergoing transformations, whether it 
may be normal cellular transformations or harmful ones, the methylation of adenosine residues in 
mRNA transcripts increases. The reason this occurs remains unclear, but it may have to do with 
an increased amount of translated proteins that cells need for specific transformations. Silencing 
the m
6
A methyltransferase is also known to considerably affect gene expression and alternative 
splicing patterns (Dominissini et al. 2012). Experiments performed by silencing METTL3 
resulted in the inactivation of specific isoforms of MDMX, which is a key gene that regulates the 
activation of the p53 gene (a tumor suppressor gene). MDMX is a gene that is needed for the 
inactivation of the p53 gene (Dominissini et al. 2012). The p53 protein is critical in regulating 
the cell cycle and preventing cancer in humans. When this gene is mutated, cells become 
immortal and begin to divide sporadically. This leads to metastatic cancers and death as a result 
of these cancerous cells affecting regular organ function. On this notion, altering the manner in 
which transcripts are methylated may one day serve to be therapeutically beneficial in treating 
cancers and other diseases that may be caused by proteins that are not translated by the lack of 
m
6
A modified transcripts. Down-regulating transcripts that are overexpressed in diseases such as 
trisomy 21 by inhibiting the m
6
A modification may prove to be a noteworthy treatment. 
Remarkably, a protein called FTO (Fat mass and obesity associated protein) catalyzes oxidative 
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demethylation of m
6
A residues in mRNA transcripts in humans (Jia et al. 2011). FTO has been 
revealed to affect energy homeostasis, human obesity, and is associated with Alzheimer’s disease 
(Jia et al. 2011). Exactly how the demethylation of these mRNA transcripts is associated with 
these factors remains to be clarified. By lowering the amount of m
6
A residues on transcripts, 
translation of proteins, regulation of mRNA metabolism, and transportation of transcripts to and 
from the nucleus may be affected in some manner. These reasons may justify targeting m
6
A or 
increasing the catalysis of the proteins that modify transcripts may serve as being medically 
beneficial.  
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